πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 202 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9404114

Antisense modulation of GCGR expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9404113

Antisense modulation of PTP1B expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9399774

Modulation of transthyretin expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9365848

Modulation of apolipoprotein C-III expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9353372

Compositions and their uses directed to huntingtin

Ionis Pharmaceuticals, Inc. Β· Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9340784

Methods and compositions for modulating alpha-1-antitrypsin expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9321799

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

Ionis Pharmaceuticals, Inc. Β· Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9322021

Methods for modulating kallikrein (KLKB1) expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9315811

Methods for modulating kallikrein (KLKB1) expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9273315

Modulation of huntingtin expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted